These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27147307)

  • 21. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
    Kim SY; Shin SJ; Jeong BH; Koh WJ
    BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro Activity of Rifabutin and Clofazimine to Macrolide-Resistant Mycobacterium abscessus Complex Clinical Isolates].
    Sürücüoğlu S; Özkütük N; Gazi H; Çavuşoğlu C
    Mikrobiyol Bul; 2023 Oct; 57(4):639-649. PubMed ID: 37885391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand.
    Sukmongkolchai S; Petsong S; Oudomying N; Prommi A; Payungporn S; Usawakidwiree W; Wongjarit K; Suwanpimolkul G; Faksri K; Suankratay C; Rotcheewaphan S
    Ann Clin Microbiol Antimicrob; 2023 Sep; 22(1):87. PubMed ID: 37735687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus.
    Maurer FP; Castelberg C; Quiblier C; Böttger EC; Somoskövi A
    J Antimicrob Chemother; 2014 Jun; 69(6):1559-63. PubMed ID: 24500188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
    Aono A; Morimoto K; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
    J Infect Chemother; 2019 Feb; 25(2):117-123. PubMed ID: 30447882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
    Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
    Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs.
    Brown-Elliott BA; Vasireddy S; Vasireddy R; Iakhiaeva E; Howard ST; Nash K; Parodi N; Strong A; Gee M; Smith T; Wallace RJ
    J Clin Microbiol; 2015 Apr; 53(4):1211-5. PubMed ID: 25653399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41).
    Maurer FP; Rüegger V; Ritter C; Bloemberg GV; Böttger EC
    J Antimicrob Chemother; 2012 Nov; 67(11):2606-11. PubMed ID: 22833642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre.
    Teri A; Sottotetti S; Arghittu M; Girelli D; Biffi A; D'Accico M; Daccò V; Gambazza S; Pizzamiglio G; Trovato A; Tortoli E; Colombo C; Cariani L
    New Microbiol; 2020 Jul; 43(3):127-132. PubMed ID: 32656572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid detection of mutations in erm(41) and rrl associated with clarithromycin resistance in Mycobacterium abscessus complex by denaturing gradient gel electrophoresis.
    Liu W; Li B; Chu H; Zhang Z; Luo L; Ma W; Yang S; Guo Q
    J Microbiol Methods; 2017 Dec; 143():87-93. PubMed ID: 29079298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic correlates of clarithromycin susceptibility among isolates of the Mycobacterium abscessus group and the potential clinical applicability of a PCR-based analysis of erm(41).
    Carvalho NFG; Pavan F; Sato DN; Leite CQF; Arbeit RD; Chimara E
    J Antimicrob Chemother; 2018 Apr; 73(4):862-866. PubMed ID: 29272470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens.
    Rüger K; Hampel A; Billig S; Rücker N; Suerbaum S; Bange FC
    J Clin Microbiol; 2014 Jan; 52(1):244-50. PubMed ID: 24197890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of the antimicrobial susceptibility and molecular profile of clarithromycin resistance in the Mycobacterium abscessus complex in Japan by variable number tandem repeat analysis.
    Kusuki M; Osawa K; Arikawa K; Tamura M; Shigemura K; Shirakawa T; Nakamura T; Nakamachi Y; Fujisawa M; Saegusa J; Tokimatsu I
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):256-259. PubMed ID: 29550059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Mixed Populations of Clarithromycin-Susceptible and -Resistant Mycobacterium abscessus Strains.
    Shallom SJ; Zelazny AM
    J Clin Microbiol; 2022 Apr; 60(4):e0169421. PubMed ID: 35313731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and antimicrobial susceptibility pattern of
    Hu Y; Li T; Liu W; Zhu D; Feng X; Chen Y; Zheng H
    Heliyon; 2024 Jul; 10(14):e34546. PubMed ID: 39113955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subspecies distribution and macrolide and fluoroquinolone resistance genetics of Mycobacterium abscessus in Korea.
    Kim J; Sung H; Park JS; Choi SH; Shim TS; Kim MN
    Int J Tuberc Lung Dis; 2016 Jan; 20(1):109-14. PubMed ID: 26688536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea.
    Kim SY; Kim CK; Bae IK; Jeong SH; Yim JJ; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Kang YA
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):107-11. PubMed ID: 25467784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance.
    Choi GE; Shin SJ; Won CJ; Min KN; Oh T; Hahn MY; Lee K; Lee SH; Daley CL; Kim S; Jeong BH; Jeon K; Koh WJ
    Am J Respir Crit Care Med; 2012 Nov; 186(9):917-25. PubMed ID: 22878281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.